Intervention Review

Intravenous immunoglobulin for myasthenia gravis

  1. Philippe Gajdos1,*,
  2. Sylvie Chevret2,
  3. Klaus V Toyka3

Editorial Group: Cochrane Neuromuscular Group

Published Online: 12 DEC 2012

Assessed as up-to-date: 11 OCT 2011

DOI: 10.1002/14651858.CD002277.pub4


How to Cite

Gajdos P, Chevret S, Toyka KV. Intravenous immunoglobulin for myasthenia gravis. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD002277. DOI: 10.1002/14651858.CD002277.pub4.

Author Information

  1. 1

    Hopital Raymond Poincaré (APHP), Service de Réanimation, 92380 Garches, Ile de France, France

  2. 2

    Hôpital Saint Louis, Departement de Biostatistique et Informatique Médicale, 75475 Paris, France

  3. 3

    University of Würzburg, Neurology, Würzburg, Bavaria, Germany

*Philippe Gajdos, Service de Réanimation, Hopital Raymond Poincaré (APHP), 104, Boulevard Raymond Poincaré, 92380 Garches, Ile de France, France. mp.gajdos@9online.fr.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 12 DEC 2012

SEARCH

  1. Current Version

    Intravenous immunoglobulin for myasthenia gravis

    Philippe Gajdos, Sylvie Chevret and Klaus V Toyka

    Version of Record online: 12 DEC 2012 | DOI: 10.1002/14651858.CD002277.pub4

Previous versions of this article and their online publication dates

  1. Version 3

    Intravenous immunoglobulin for myasthenia gravis

    Philippe Gajdos, Sylvie Chevret and Klaus V Toyka

    Version of Record online: 23 JAN 2008 | DOI: 10.1002/14651858.CD002277.pub3

  2. Version 2

    Intravenous immunoglobulin for myasthenia gravis

    P Gajdos, S Chevret and K Toyka

    Version of Record online: 19 APR 2006 | DOI: 10.1002/14651858.CD002277.pub2

  3. Version 1

    Intravenous immunoglobulin for myasthenia gravis

    P Gajdos, S Chevret and K Toyka

    Version of Record online: 22 APR 2003 | DOI: 10.1002/14651858.CD002277